LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Stryker’s $228 Million Award Against Zimmer Slashed by $158 Million
Legal & Regulatory and Reimbursement

Stryker’s $228 Million Award Against Zimmer Slashed by $158 Million

December 23, 2014 2 min read Premium comments

Advertisement

Stryker’s $228 Million Award Against Zimmer Slashed by $158 Million
Pulsavac Plus / Source: Zimmer Holdings, Inc.
Secondary

The top U.S. patent court has slashed Stryker Corporation’s $228 million damage award from Zimmer Holdings Inc over a surgical cleaning wand to $70 million. That’s a hefty secular holiday gift.

Stryker sued Zimmer back in 2010, claiming Zimmer’s Pulsavac Plus device for cleaning wounds during orthopedic surgical procedures infringed three of its patents. A federal jury in Grand Rapids, Michigan, agreed with the Michigan-based Stryker last February and awarded the company $70 million in lost profits. However, the jury also found Zimmer’s infringement as being willful. That resulted in the federal judge tripling the damages. After additional fees, he raised the award to the $228 million.

The judge said Zimmer had all but instructed its engineers to copy the Stryker product.

Appeals Court: “Zimmer’s Conduct Not Willful”

Zimmer appealed the “willful” part and on December 19, 2014, a three-judge panel of the U.S. Court of Appeals for the Federal Circuit agreed with Zimmer. Chief Judge Sharon Prost said, Zimmer’s defenses were reasonable and that the company did not act recklessly. The panel also vacated the original district judge’s decision to award legal fees to Stryker and sent the case back for review to see if Zimmer still has to pay the fees because of allegations of litigation misconduct.

The companies are the main competitors for the handheld surgical tools, which are battery powered and replace older, bulkier machines that had to be wheeled around and plugged in.

Zimmer’s guilt of patent infringement stands, however. The judge’s original 58-page opinion outlined Stryker’s innovation in coming up with their device to replace the bulky machines. He said Zimmer was losing market share, so it hired someone to “make one for us, ” which resulted in a product that looked and functioned like Stryker’s. Zimmer, according to the judge, recouped some market share until it was forced to pull its product from the market in 2007 because of technical problems and complaints. It reentered the market in December 2008, he wrote.

“Zimmer chose a high-risk/high-reward strategy of competing immediately and aggressively in the pulsed lavage market and opted to worry about the potential legal consequences later…A $70 million verdict sounds large in the abstract, but in context, it may not be enough, without enhancement, to deter infringing conduct, ” wrote the judge in his opinion.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy